NYSE American - Delayed Quote USD

cbdMD, Inc. (YCBD)

1.0000 +0.0008 (+0.08%)
At close: April 19 at 3:59 PM EDT
0.9800 -0.02 (-2.00%)
After hours: April 19 at 6:56 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. T. Ronan Kennedy Interim CEO, CFO & Principal Executive Officer 275k -- 1980
Dr. Sibyl Swift Ph.D. CSO, VP of Regulatory Affairs & Director -- -- 1981
Zeb Booker Chief Technology Officer -- -- --
Mr. John Weston Director of Investor Relations -- -- --
Mr. Lance Blundell General Counsel -- -- 1971
Robert Pettway Director of Public Relations -- -- --
Mr. Francisco Mangual Senior VP of Sales -- -- 1979
Ms. Shannon Charles Chief Marketing Officer -- -- --
Mr. David Johnson Senior VP of Business Development -- -- 1970

cbdMD, Inc.

8845 Red Oak Boulevard
Charlotte, NC 28217
United States
704 445 3060 https://www.cbdmd.com
Sector: 
Healthcare
Full Time Employees: 
52

Description

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

Corporate Governance

cbdMD, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 13, 2024 - May 17, 2024
cbdMD, Inc. Earnings Call

Related Tickers

CWBHF Charlotte's Web Holdings, Inc.
0.2198
+4.22%
 
SNOA Sonoma Pharmaceuticals, Inc.
0.1500
-4.21%
 
GPFT Grapefruit USA, Inc.
0.0012
-4.62%
 
CVSI CV Sciences, Inc.
0.0398
+8.09%
 
BGXX Bright Green Corporation
0.2123
-4.63%
 
CLVR Clever Leaves Holdings Inc.
4.0807
-0.47%
 
CSUI Cannabis Suisse Corp.
0.0230
+51.32%
 
ROMJF Rubicon Organics Inc.
0.2672
-1.67%
 
VIVE.ST Vivesto AB
0.3150
-0.47%
 
ATTBF Abattis Bioceuticals Corp.
0.0000
0.00%